ADIPOQ and fatty liver disease: It can also decrease hepatic steatosis through lipid homeostasis by increasing the inhibition of CD36 and PPARγ by the cAMP response element-binding (CREB) protein and the adiponectin precursor, ADIPOQ [64,72,77].